0000899243-19-016201.txt : 20190610 0000899243-19-016201.hdr.sgml : 20190610 20190610164703 ACCESSION NUMBER: 0000899243-19-016201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190606 FILED AS OF DATE: 20190610 DATE AS OF CHANGE: 20190610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Audia James E CENTRAL INDEX KEY: 0001746115 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 19889019 MAIL ADDRESS: STREET 1: 215 FIRST STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-06 0 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001746115 Audia James E C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 9.12 2019-06-06 4 A 0 13171 0.00 A 2029-06-05 Common Stock 13171 13171 D This option was granted on June 6, 2019 and will vest as to all shares underlying the option on June 6, 2020, subject to continued service. /s/ Karen Valentine, as attorney-in-fact for James E. Audia 2019-06-10